default author photo

Lorel Schmitzberger

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

42

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

DNA electroporation of HIV Env elicits unique pattern of immune responses compared to other methods of immunogen delivery, including robust CD8+ responses and memory B cell responses with muted serum antibody levels when boosted with recombinant protein

Number of pages: 32 Posted: 01 Oct 2025
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Alabama at Birmingham, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, affiliation not provided to SSRN, Duke University - Duke Human Vaccine Institute, Duke University, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Department of Surgery, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute, National Institutes of Health, affiliation not provided to SSRN, Columbia University, Vanderbilt University - Division of Infectious Diseases, affiliation not provided to SSRN, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, affiliation not provided to SSRN, Government of the United States of America - Vaccine Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and University of Pennsylvania - Vaccine Center
Downloads 42 (1,157,785)

Abstract:

Loading...

HIV-1 vaccine, DNA vaccine, Clinical Trial, neutralizing antibodies, B cell response, CD8+ T cell response